Laboratorios Farmaceuticos Rovi company profile

ROVI · BME · EUR

Compare Laboratorios Farmaceuticos Rovi
€68.50Change from previous close: −1.58%Absolute change: −€1.10

Close · November 17, 2026

Company profile

Laboratorios Farmaceuticos Rovi has 1,950 employees and is headquartered in Pozuelo de Alarcón, Spain.

Rovi's prescription medicines, including Ameride, Exxiv, Neparvis and Mysimba, form the core of its activity, and the group also sells hospital products such as contrast agents and catheter care under the Fibrilin name. Its portfolio spans cardiology, women's health, anaesthesia and pain, the central nervous system, urology, endocrinology and respiratory care. Beyond its own brands, the company runs contract manufacturing for injectable forms, covering sterile filling, labelling, serialisation and packaging, and it also makes low-molecular-weight heparin. Its markets include Spain, the European Union, other OECD countries and other regions.

In the fiscal year ended December 2025, revenue reached 743.5 million euros, down 2.7% from the previous year, and net profit was 140.4 million euros. The company employed 1,950 people and is headquartered in Pozuelo de Alarcón, Spain. Incorporated in 1946, it operates as a subsidiary of Norbel Inversiones, S.L.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
Spain
Headquarters
Calle José Isbert, 2, 28223, Pozuelo de Alarcón
Employees
1,950
Chief executive
Juan Lopez-Belmonte Encina
Founded
1946
Fiscal year
January - December
Listing
ROVI · BME
Indices
IBEX 35
Currency
EUR
ISIN
ES0157261019
Website
rovi.es

Laboratorios Farmaceuticos Rovi and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Laboratorios Farmaceuticos RoviROVISpain$3.93B1,95020.2%17.4
Siegfried HoldingSFZNSwitzerland$3.53B4,45416.7%17.3
AlmirallALMSpain$2.53B2,1089.6%32.1
FagronFAGRBelgium$1.9B4,88014.3%18.8
H. LundbeckHLUN.ADenmark$8.49B5,00024.4%14.2
Faes FarmaFAESpain$1.73B2,67713.0%18.7

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Laboratorios Farmaceuticos Rovi with its competitors